Vimarsana
Biggest News Aggregation in the World

Page 2 - Positive Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Positive Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Positive Data Today - Breaking & Trending Today

Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030 - Vimarsana News

Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030

/PRNewswire/ -- According to the Centers for Disease Control and Prevention, arthritis affects approximately one in every four Americans, or 58.5 million...

Financialnewsmedia.com: Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030 - Vimarsana News

Financialnewsmedia.com: Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030

FinancialNewsMedia.com News Commentary Palm Beach, Fla., Dec. 30, 2022 /PRNewswire/ -- According to the Centers for Disease Control and Prevention, arthritis affects approximately one in

BridgeBio Bounces Back with Promising Canavan, MD Data - Vimarsana News

BridgeBio Bounces Back with Promising Canavan, MD Data

After suffering a blow to its multi-billion dollar liver cancer program, BridgeBio presented early but promising data in ultra-rare Canavan disease.

Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates - Vimarsana News

Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates

- Positive Data from the Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia Presented at European Hematology Association Meeting 2022 - - Positive Data from the Ongoing Phase 2 Study... | August 12, 2022

INOVIO Reports Financial Results and Highlights for the Second Quarter 2022 - Vimarsana News

INOVIO Reports Financial Results and Highlights for the Second Quarter 2022

/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious...